Search results
UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
Michelle Wang joined the UCSF faculty in 2024 with the Department of Bioengineering and Therapeutic Sciences. She is also involved in the Master’s Program of Artificial Intelligence and Computational Drug Discovery and Development at the School of Pharmacy.
Michelle Wang, DPharm PSPG PhD Student Michelle is currently a PhD student with the Pharmaceutical Sciences and Pharmacogenomics program. Michelle completed her undergraduate degree in chemistry at University of Washington and received her PharmD degree from the Ohio State University.
Experience: The Research Institute - Nationwide Children's Hospital · Education: University of California, San Francisco · Location: San Francisco · 156 connections on LinkedIn.
- The Research Institute - Nationwide Children's Hospital
The laboratory of Dr. Marina Sirota at UCSF is seeking highly motivated investigators to develop and study novel approaches in translational bioinformatics, or the application of analytic and interpretive methods to optimize the transformation of genomic and clinical data into precision medicine.
Feb 1, 2024 · Clinical Pharmacology Fellow Michelle Wang, PharmD, PhD, will be joining the AICD3 program with a new appointment as assistant professor in BTS, contributing her expertise in using novel AI computational methods to improve the use of novel therapeutics.
Michelle Wang earned her PharmD degree from the Ohio State University and her PhD degree in pharmaceutical sciences and pharmacogenomics from UCSF. Her postdoctoral training included regulatory sciences at the FDA, clinical informatics research at the Bakar Computational Health Sciences Institute, and a clinical pharmacology and therapeutics ...
Overview. Our research focuses on expansion of the genetic code to incorporate unnatural amino acids into proteins; these new amino acids are designed and harnessed to understand protein and cellular function and to develop biotherapeutics.
Michelle Wang. UCSF University of California, San Francisco| UCSF · Department of Bioengineering and Therapeutic Sciences (Pharmacy) Contact. Connect with experts in your field. Join...
Michelle Wang's 4 research works with 9 citations and 156 reads, including: ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer:...
